Image de couverture de livre

SMPR: A structure-enhanced multimodal drug-disease prediction model for drug repositioning and cold start

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Dong, Xin, Miao, Rui, Zhang, Suyan, Jia, Shuaibing, Zhang, Leifeng, Liang, Yong, Zhang, Jianhua, Zhu, Yi Zhun
Format:	Preprint
Publié:	2025
Sujets:	Machine Learning
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Node2Vec-DGI-EL: A Hierarchical Graph Representation Learning Model for Ingredient-Disease Association Prediction
par: Zhang, Leifeng, et autres
Publié: (2025)

Boosting drug-disease association prediction for drug repositioning via dual-feature extraction and cross-dual-domain decoding
par: Zhu, Enqiang, et autres
Publié: (2024)

Fundamental and Clinical Pharmacology of drug repositioning
par: Lars Petter Jordheim
Publié: (2025)

Exploring drug repositioning possibilities of kinase inhibitors via molecular simulation**
par: Qing‐Xin Wang, et autres
Publié: (2024)

Dynamical model-based experiment design for drug repositioning
par: Aalto, Atte, et autres
Publié: (2025)

How many drugs are repositioned each year in Europe?
par: Johnathon Liddicoat, et autres
Publié: (2024)

DeepDR: an integrated deep-learning model web server for drug repositioning
par: Jin, Shuting, et autres
Publié: (2025)

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction
par: Zhou, Changjian, et autres
Publié: (2024)

MFCN‐DDI: Capsule network based on multimodal feature for multitype drug–drug interaction prediction
par: Jiayi Lu, et autres
Publié: (2025)

GRAM-DTI: adaptive multimodal representation learning for drug target interaction prediction
par: Jiang, Feng, et autres
Publié: (2025)

Network‐based identification of key proteins and repositioning of drugs for non‐small cell lung cancer
par: Oluwatosin Maryam Adeyemo, et autres
Publié: (2024)

Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade
par: Mahitab Bayoumi, et autres
Publié: (2024)

Deep learning for drug‐drug interaction prediction: A comprehensive review
par: Xinyue Li, et autres
Publié: (2024)

Benchmarking drug-drug interaction prediction methods: a perspective of distribution changes
par: Shen, Zhenqian, et autres
Publié: (2024)

A substructure‐aware graph neural network incorporating relation features for drug–drug interaction prediction
par: Liangcheng Dong, et autres
Publié: (2024)

New role of platelets in schizophrenia: predicting drug response
par: Yamin Zhang, et autres
Publié: (2024)

Causal effects of lipid‐lowering drugs on inflammatory skin diseases: Evidence from drug target Mendelian randomisation
par: Chenyang Zang, et autres
Publié: (2024)

Comorbidities, comedications and potential drug–drug interactions among people living with HIV in China
par: Yidan Zhao, et autres
Publié: (2025)

The role of cytokines in ovarian cancer drug resistance
par: Lu Wang, et autres
Publié: (2025)

MCLRP: enhanced prediction of anticancer drug response through low-rank matrix completion and transcriptomic profiling.
par: Wang, Kun, et autres
Publié: (2025)

Evaluation of potential drug–drug interactions with medical cannabis
par: Jessie Jia Yi Ho, et autres
Publié: (2024)

Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma
par: Guole Nie, et autres
Publié: (2024)

MD-Syn: Synergistic drug combination prediction based on the multidimensional feature fusion method and attention mechanisms
par: Ge, XinXin, et autres
Publié: (2025)

Neutrophil hitchhiking: Riding the drug delivery wave to treat diseases
par: Menghui Wang, et autres
Publié: (2024)

Prospects of antidiabetic drugs in the treatment of neurodegenerative disease
par: Lidan Hu, et autres
Publié: (2024)

Advancing antihypertensive drug development
par: Fay Pu, et autres
Publié: (2025)

Accurate and interpretable drug-drug interaction prediction enabled by knowledge subgraph learning
par: Wang, Yaqing, et autres
Publié: (2023)

DDI‐Transform: A neural network for predicting drug‐drug interaction events
par: Jiaming Su, et autres
Publié: (2024)

Long‐term fracture conductivity in tight reservoirs
par: Chuanliang Yan, et autres
Publié: (2024)

Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
par: Jiyuan Liu, et autres
Publié: (2024)

Rethinking the generalization of drug target affinity prediction algorithms via similarity aware evaluation
par: Zhang, Chenbin, et autres
Publié: (2025)

Patient versus physician preferences for lipid‐lowering drug therapy: A discrete choice experiment
par: Lingli Zhang, et autres
Publié: (2024)

Implications of drug resistance in leprosy: disease course, reactions and the use of novel drugs
par: Kabir Sardana, et autres
Publié: (2024)

Nanotechnology‐driven strategies to enhance the treatment of drug‐resistant bacterial infections
par: Junjie Zhang, et autres
Publié: (2024)

Therapeutic drug monitoring, liquid biopsies or pharmacogenomics for prediction of human drug metabolism and response
par: Magnus Ingelman‐Sundberg, et autres
Publié: (2024)

Nanostructured drug delivery systems for posterior segment eye diseases: Strategies to defy ocular barriers
par: Yifan Shen, et autres
Publié: (2025)

Drug-disease networks and drug repurposing
par: Polanco, Austin, et autres
Publié: (2025)

ADCNet: a unified framework for predicting the activity of antibody-drug conjugates
par: Chen, Liye, et autres
Publié: (2024)

PDCNet: a benchmark and general deep learning framework for activity prediction of peptide-drug conjugates
par: Liu, Yun, et autres
Publié: (2025)

GCARDTI: Drug–target interaction prediction based on a hybrid mechanism in drug SELFIES
par: Yinfei Feng, et autres
Publié: (2024)